Microbix Biosystems ($MBX.TO) FINS Review
2024 Annuals
Multiple requests on this one. The stock has been relatively flat from where they began the year, but it is up about 33% in the past few weeks and have continued with that momentum since their financials were released last week.
First review and look at them. I know very little about them so let’s dig into their recently released annual statements.